HR:NYE-Healthcare Realty Trust Incorporated (USD)

EQUITY | REIT - Healthcare Facilities | New York Stock Exchange

Last Closing

USD 14.14

Change

0.00 (0.00)%

Market Cap

USD 3.38B

Volume

3.60M

Analyst Target

USD 31.27
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Healthcare Realty Trust Inc is a real estate investment trust which owns, acquires, manages, finances and develops income-producing real estate properties associated with the delivery of outpatient healthcare services throughout the United States.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-28 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+1.11 (+0.81%)

USD 81.50B
VTR Ventas Inc

+0.45 (+0.68%)

USD 27.31B
DOC Healthpeak Properties Inc

+0.20 (+0.89%)

USD 16.16B
CTRE CareTrust REIT Inc.

+0.89 (+2.79%)

USD 4.68B
AHR American Healthcare REIT, Inc.

+0.62 (+2.35%)

USD 4.03B
NHI National Health Investors Inc

+0.98 (+1.27%)

USD 3.32B
LTC LTC Properties Inc

+0.92 (+2.42%)

USD 1.56B
UHT Universal Health Realty Income..

+0.43 (+1.08%)

USD 0.57B
CHCT Community Healthcare Trust Inc

+1.19 (+6.70%)

USD 0.49B
GMRE-PA Global Medical REIT Inc

+0.05 (+0.20%)

USD 0.41B

ETFs Containing HR

SMDY 1.20 % 0.00 %

N/A

N/A
IYR iShares U.S. Real Estate .. 0.00 % 0.42 %

+0.48 (+0%)

N/A
XRE:CA iShares S&P/TSX Capped RE.. 0.00 % 0.61 %

-0.03 (0%)

CAD 1.34B

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -17.93% 21% F 8% B-
Dividend Return 1.80% 64% D 75% C
Total Return -16.13% 21% F 9% A-
Trailing 12 Months  
Capital Gain -28.51% 14% F 8% B-
Dividend Return 6.27% 50% F 79% B-
Total Return -22.24% 14% F 10% F
Trailing 5 Years  
Capital Gain -54.21% 25% F 10% F
Dividend Return 35.36% 83% B 90% A-
Total Return -18.85% 25% F 17% F
Average Annual (5 Year Horizon)  
Capital Gain -14.57% 21% F 6% D-
Dividend Return -6.21% 21% F 11% F
Total Return 8.36% 100% F 94% A
Risk Return Profile  
Volatility (Standard Deviation) 11.70% 93% A 77% C+
Risk Adjusted Return -53.06% 14% F 7% C-
Market Capitalization 3.38B 73% C 77% C+

Key Financial Ratios

  Ratio vs. Industry/Classification (REIT - Healthcare Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 57.40 14% 3%
Price/Book Ratio 0.79 93% 84%
Price / Cash Flow Ratio 10.78 73% 35%
Price/Free Cash Flow Ratio 14.35 57% 27%
Management Effectiveness  
Return on Equity -3.86% 20% 23%
Return on Invested Capital 0.40% 13% 26%
Return on Assets 0.24% 7% 24%
Debt to Equity Ratio 68.08% 67% 49%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.